Cooperation of the transcriptional coactivators CBP and p300 with Stat6

Journal of Interferon and Cytokine Research

Volumn 19, Issue 7, 1999, Pages 711-722

  McDonald, Christine ^a   Reich, Nancy C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; PROTEIN P300; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEPG2; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ACETYLATION; ADENOVIRUS E1A PROTEINS; CELL LINE; CREB-BINDING PROTEIN; GENE EXPRESSION; HUMANS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0032797730     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313550     Document Type: Article

References (62)

1. PAUL, W.E. (1991). Interleukin-4: aprototypic immunoregulatory lymphokine. Blood 77, 1859-1870.
2. BROWN, M.A., and HURAL, J. (1997). Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17, 1-32.
3. CHOMARAT, P., and BANCHEREAU, J. (1997). An update on interleukin-4 and its receptor. Eur. Cytokine Netw. 8, 333-344.
4. KOTANIDES, H., and REICH, N.C. (1993). Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262, 1265-1267.
5. KÖHLER, I., and RIEBER, E.P. (1993). Allergy-associated le and Fce receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 23, 3066-3071.
6. SCHINDLER, C., KASHLEVA, H., PERNIS, A., PINE, R., and ROTHMAN, P. (1994). STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J. 13, 1350-1356.
7. KOTANIDES, H., and REICH, N.C. (1996). InterIeukin-4-induced Stat6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J. Biol. Chem. 271, 25555-25561.
8. HOU, J., SCHINDLER, U., HENZEL, W.J., HO, T.C., BRASSEUR, M., and MCKNIGHT, S.L. (1994). An interleukin4-induced transcription factor: IL-4 Stat. Science 265, 1701-1706.
9. QUELLE, F.W., SHIMODA, K., THIERFELDER, W., FISCHER, C., KIM, A., RUBEN, S.M., CLEVELAND, J.L., PIERCE, J.H., KEEGAN, A.D., NELMS, K., PAUL, W.E., and IHLE, J.N. (1995). Cloning of murine Stato and human Stat6, proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15, 3336-3343.
10. DARNELL, J.E., Jr., KERR, I.M., and STARK, G.R. (1994). Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
11. DARNELL, J.E., Jr. (1997). Stats and gene regulation. Science 277, 1630-1635.
12. IHLE, J.N., WITTHUHN, B.A., QUELLE, F.W., YAMAMOTO, K., and SILVENNOINEN, O. (1995). Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
13. KOTANIDES, H., MOCZYGEMBA, M., WHITE, M.F., and REICH, N.C. (1995). Characterization of the interleukin-4 nuclear activated factor/Stat and its activation independent of the insulin receptor substrate proteins. J. Biol. Chem. 270, 19481-19486.
14. WANG, L.-M., KEEGAN, A.D., LI, W., LIENHARD, G.E., PACINI, S., GUTKIND, J.S., MYERS M.G., JR., SUN, X.-J., WHITE, M.F., AARONSON, S.A., PAUL, W.E., and PIERCE, J.H. (1993). Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90, 4032-4036.
15. YENUSH, L., and WHITE, M.F. (1997). The IRS-signalling system during insulin and cytokine action. BioEssays 19, 491-500.
16. SHIMODA, K., VAN DEURSEN, J., SANGSTER, M.Y., SARAWAR, S.R., CARSON, R.T., TRIPP, R.A., CHU, C., QUELLE, F.W., NOSAKA, T., VIGNALI, D.A.A., DOHERTY, P.C., GROS VELD, G., PAUL, W.E., and IHLE, J.N. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
17. KAPLAN, M.H., SCHINDLER, U., SMILEY, S.T., and GRUSBY, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319.
18. TAKEDA, K., TANAKA, T., SHI, W., MATSUMOTO, M., MINAMI, M., KASHIWAMURA, S., NAKANISHI, K., YOSHIDA, N., KISHIMOTO, T., and AKIRA, S. ( 1996). Essential role of Stato in IL-4 signalling. Nature 380, 627-630.
19. KÜHN, R., RAJEWSKY, K., and MÜLLER, W. (1991). Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
20. KOPF, M., LE GROS, G., BACHMANN, M., LAMERS, M.C., BLUETHMANN, H., and KÖHLER, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
21. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 10838-10843.
22. MIKITA, T., CAMPBELL, D., WU, P., WILLIAMSON, K., and SCHINDLER, U. (1996). Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 16, 5811-5820.
23. LU, B., REICHEL, M., FISHER, D.A., SMITH, J.F., and ROTHMAN, P. (1997). Identification of a Stat6 domain required for II-4-induced activation of transcription. J. Immunol. 159, 1255-1264.
24. MORIGGL, R., BERCHTOLD, S., FRIEDRICH, K., STANDKE, G.J.R., KAMMER, W., HEIM, M., WISSLER, M., STÖCKLIN, E., GOUILLEUX, F., and GRONER, B. (1997). Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol. Cell. Biol. 17, 3663-3678.
25. BHATTACHARYA, S., ECKNER, R., GROSSMAN, S., OLDREAD, E., ARANY, Z., D'ANDREA, A., and LIVINGSTON, D.M. (1996). Cooperation of Stat2 and p300/CBP in signalling induced by Interferon-α. Nature 383, 344-347.
26. ZHANG, J.J., VINKEMEIER, U., GU, W., CHAKRAVARTI, D., HORVATH, C.M., and DARNELL, J.E., JR. (1996). Two contact regions between Stat1 and CBP/p300 in interferon γ signaling. Proc. Natl. Acad. Sci. USA 93, 15092-15096.
27. HORVAI, A.E., XU, L., KORZUS, E., BRARD, G., KALAFUS, D., MULLEN, T.-M., ROSE, D.W., ROSENFELD, M.G., and GLASS, C.K. (1997). Nuclear integration of Jak/Stat and Ras/AP1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94, 1074-1079.
28. PFITZNER, E., JÄHNE, R., WISSLER, M., STOECKLIN, E., and GRONER, B. (1998). P300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12, 1582-1593.
29. JANKNECHT, R., and HUNTER, T. (1996). Transcriptional control: versatile molecular glue. Curr. Biol. 6, 951-954.
30. ECKNER, R. (1996). p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377, 685-688.
31. CHRIVIA, J.C., KWOK, R.P.S., LAMB, N., HAGIWARA, M., MONTMINY, M.R., and GOODMAN, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
32. ECKNER, R., EWEN, M.E., NEWSOME, D., GERDES, M., DECAPRIIO, J.A., LAWRENCE, J.B., and LIVINGSTON, D.M. (1994), Molecular cloning and functional analysis of the adenovirus E1 A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
33. OGRYZKO, V.V., SCHILTZ, R.L., RUSSANOVA, V., HOWARD, B.H., and NAKATANI, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
34. BANNISTER, A.J., and KOUZARIDES, T. (1996). The CBP coactivator is a histone acetyltransferase. Nature 384, 641-643.
35. YANG, X.-J., OGRYZKO, V.V., NISHIKAWA, J., HOWARD, B.H., and NAKATANI, Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
36. CHEN, H., LIN, R.J., SCHILTZ, R.L., CHAKRAVARTI, D., NASH, A., NAGY, L., PRIVALSKY, M.L., NAKATANI, Y., and EVANS, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
37. NAKAJIMA, T., UCHIDA, C., ANDERSON, S.F., LEE, C.-G., HURWITZ, J., PARVIN, J.D., and MONTMINY, M. ( 1997). RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90, 1107-1112.
38. KWOK, R.P.S., LUNDBLAD, J.R., CHRIVIA, J.C., RICHARDS, J.P., BÄCHINGER, H.P., BRENNAN, R.G., ROBERTS, S.G.E., GREEN, M.R., and GOODMAN, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
39. YUAN, W., CONDORELLI, G., CARUSO, M., FELSANI, A., and GIORDANO, A. (1996). Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271, 9009-9013.
40. NEISH, A.S., ANDERSON, S.F., SCHLEGEL, B.P., WEI, W., and PARVIN, J.D. (1998). Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 26, 847-853.
41. WOLFFE, A.P., and PRUSS, D. (I996). Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 84, 817-819.
42. STRUHL, K. (1998). Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606.
43. PETRIJ, F., GILES, R.H., DAUWERSE, H.G., SARIS, J.J., HENNEKAM, R.C.M., MASUNO, M., TOMMERUP, N., VAN OMMEN, G.-J.B., GOODMAN, R.H., PETERS, D.J.M., and BREUNING, M.H. (1995). Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351.
44. YAO, T.-P., OH, S.P., FUCHS, M., ZHOU, N.-D., CH'NG, L.-E., NEWSOME, D., BRONSON, R.T., LI, E., LIVINGSTON, D.M., and ECKNER, R. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372.
45. GUAN, K., and DIXON, J.E. (1991). Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192, 262-267.
46. MARTINEZ-MOCZYGEMBA, M., GUTCH, M.J., FRENCH, D.L., and REICH, N.C. (1997). Distinct Stat structure promotes interaction of Stat2 with the p48 subunit of the interferon-α-stimulated transcription factor ISGF3. J. Biol. Chem. 272, 20070-20076.
47. GUTCH, M.J., and REICH, N.C. (1991). Repression of the interferon signal transduction pathway by the adenovirus E1 A oncogene. Proc. Natl. Acad. Sci. USA 88, 7913-7917.
48. DIGNAM, J.D., LEBOVITZ, R.M., and ROEDER, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isoalted mammailian nuclei. Nucleic Acids Res. 11, 1475-1489.
49. SCHINDLER, U., WU, P., ROTHE, M., BRASSEUR, M., and MCKNIGHT, S.L. (1995). Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2, 689-697.
50. ARANY, Z., NEWSOME, D., OLDREAD, E., LIVINGSTON, D.M., and ECKNER, R. (1995). A family of transcriptional adaptor proteins targeted by the E1 A oncoprotein. Nature 374, 81-84.
51. LUNDBLAD, J.R., KWOK, R.P.S., LAURANCE, M.E., HARTER, M.L., and GOODMAN, R.H. (1995). Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88.
52. GU, W., and ROEDER, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
53. TORCHIA, J., ROSE, D.W., INOSTROZA, J., KAMEI, Y., WESTIN, S., GLASS, C.K., and ROSENFELD, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
54. HEERY, D.M., KALKHOVEN, E., HOARE, S., and PARKER, M.G. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.
55. TROUCHE, D., COOK, A., and KOUZARIDES, T. (1996). The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24, 4139-4145.
56. MÜLLER, M., LAXTON, C., BRISCOE, J., SCHINDLER, C, IMPROTA, T., DARNELL, J.E., JR., STARK, G.R., and KERR, I.M. (1993). Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12, 4221-4228.
57. QURESHI, S.A., LEUNG, S., KERR, I.M., STARK, G.R., and DARNELL, J.E., JR. (1996). Function of Stat2 protein in transcriptional activation by alpha interferon. Mol. Cell. Biol. 16, 288-293.
58. WANG, D., STRAVOPODIS, D., TEGLUND, S., KITAZAWA, J., and IHLE, J.N. (1996). Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16, 6141-6148.
59. SASSE, J., HEMMANN, U., SCHWARTZ, C., SCHNIERT-SHAUER, U., HEESEL, B., LANDGRAF, C., SCHNEIDER-MERGENER, J., HEINRICH, P.C., and HORN, F. (1997). Muta- tional analysis of acute-phase response factor/Stat3 activation and dimerization. Mol. Cell. Biol. 17, 4677-4686.
60. OHMORI, Y., and HAMILTION, T.A. (1998). Siato is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J. Biol. Chem. 273, 29202-29209.
61. WEN, Z., ZHONG, Z., and DARNELL, J.E., JR. (1995). Maximal activation of transcription by Stall and Stat3 requires both tyro- sine and serine phosphorylation. Cell 82, 241-250.
62. ZHANG, J.J., ZHAO, Y., CHAIT, B.T., LATHEM, W.W., RITZI, M., KNIPPERS, R., and DARNELL, J.E., JR. (1998). Ser727-dependent recruitment of MCM5 by Statla in IFN-γ-induced transcriptional activation. EMBO J. 17, 6963-6971.